SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $306,000 | -34.3% | 131,423 | +31.1% | 0.00% | – |
| Q4 2021 | $466,000 | -40.1% | 100,274 | -1.6% | 0.00% | – |
| Q3 2021 | $778,000 | -43.1% | 101,916 | -27.8% | 0.00% | -100.0% |
| Q2 2021 | $1,368,000 | +24.5% | 141,139 | +6.2% | 0.00% | 0.0% |
| Q1 2021 | $1,099,000 | +46.9% | 132,888 | +21.3% | 0.00% | – |
| Q4 2020 | $748,000 | +28.1% | 109,557 | +109.3% | 0.00% | – |
| Q3 2020 | $584,000 | +105.6% | 52,344 | +15.7% | 0.00% | – |
| Q2 2020 | $284,000 | +446.2% | 45,238 | +60.5% | 0.00% | – |
| Q1 2020 | $52,000 | -48.5% | 28,178 | -5.5% | 0.00% | – |
| Q4 2019 | $101,000 | -74.2% | 29,818 | -83.7% | 0.00% | – |
| Q3 2019 | $392,000 | -53.0% | 183,232 | -41.3% | 0.00% | -100.0% |
| Q2 2019 | $834,000 | -42.8% | 312,406 | +1.8% | 0.00% | 0.0% |
| Q1 2019 | $1,457,000 | +1518.9% | 306,798 | +1396.6% | 0.00% | – |
| Q3 2018 | $90,000 | -76.7% | 20,500 | -61.7% | 0.00% | – |
| Q2 2018 | $386,000 | +109.8% | 53,577 | +413.7% | 0.00% | – |
| Q2 2015 | $184,000 | – | 10,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 5,000,000 | $9,200,000 | 0.43% |
| SABBY MANAGEMENT, LLC | 287,386 | $529,000 | 0.22% |
| Virtus ETF Advisers LLC | 88,342 | $163,000 | 0.07% |
| Donald L. Hagan, LLC | 26,002 | $67,000 | 0.06% |
| MinichMacGregor Wealth Management, LLC | 26,002 | $67,000 | 0.06% |
| Pegasus Asset Management, Inc. | 15,000 | $28,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 50,000 | $92,000 | 0.02% |
| S&T BANK/PA | 38,853 | $71,000 | 0.02% |
| Integrated Wealth Concepts LLC | 108,391 | $199,000 | 0.02% |
| Kore Private Wealth LLC | 37,302 | $69,000 | 0.02% |